The Securities Regulatory Commission has seriously investigated and dealt with the case of serious financial fraud of *ST Changyao (300391.SZ).

Intelligence Finance APP learned that recently, the China Securities Regulatory Commission issued an administrative penalty notice to the listed company Changjiang Pharmaceutical Holdings Co., Ltd. (*ST Changyao) for suspected false recording of financial data such as periodic reports. After investigation, *ST Changyao (300391.SZ) has falsely inflated revenue and profits for three consecutive years, violating securities laws and regulations. The CSRC plans to fine the listed company 10 million yuan, fine a total of 31 million yuan for 14 responsible persons, and impose a lifetime ban on the former general manager of the company, Luo Ming, from the securities market. *ST Changyao is suspected of involving significant illegal activities that may lead to mandatory delisting, and the Shenzhen Stock Exchange will initiate delisting procedures in accordance with the law.